Publications by authors named "Ali Alkan"

Claim this Profile
T
The efficacy of targeted therapies in metastatic squamous cell carcinoma of the lung: a Turkish Oncology Group multicentre study.
Bilgeşah Kılıçtaş, Murat Araz, Ahmet Oruç, Dilek Çağlayan, Gamze Emin, Ali Alkan

J Chemother· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular co-alteration patterns of RICTOR-mutant metastatic lung adenocarcinomas: a single-center cohort study.
Mehmet Berkay Ozata, Ali Aytac, Ibrahim Halil Erdogdu, Ali Alkan, Ozgur Tanriverdi

Virchows Arch· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the prognostic value of the magnesium-immune prognostic score (MIPS) in metastatic non-small cell lung cancer receiving Nivolumab.
Sait Kitapli, Melih Akpunar, Ali Alkan, Ozgur Tanriverdi

Clin Transl Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medical oncologists' dance with international guidelines and national reimbursement: insights from a survey in Türkiye.
Ozgur Tanriverdi, Melek Ozdemir, Emre Hafizoglu, Taliha Guclu, Elvina Almurodova, Ali Alkan

Expert Rev Pharmacoecon Outcomes Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum amylase level as a predictive biomarker for persistent grade 1 chemotherapy-associated oral mucositis: a retrospective cross-sectional study.
Nursema Ozdemir, Ali Alkan, Ozgur Tanriverdi

Int J Clin Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determination of the Relationship between Electromyography-Proven Oxaliplatin-Related Peripheral Neuropathy and Serum Uric Acid Level.
Ozgur Tanriverdi, Yavuz Selim Dilmen, Burak Arslan, Gulnihal Kutlu, Ali Alkan

Oncol Res Treat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental distributions of phthalates in sediments affected by municipal wastewater in the South-eastern Black Sea.
Nigar Alkan, Ali Alkan, Bekir Salih, Cemre Yilmaz, Osman Üçüncü

Chemosphere· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancer.
Yasin Sezgin, Oğur Karhan, Mehmet Naci Aldemir, Muslih Ürün, Berrak Mermit Erçek, Ali Alkan

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aşık, Ziya Kalkan

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When tomorrow starts without me.
Ali Alkan, Aslı Alkan, Özgür Tanrıverdi

Support Care Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wearing a surgical mask during chemotherapy session is safe.
Ali Alkan, Mert Şahin, Ece Dilan Bozkurt, Aslı Alkan, Özgür Tanrıverdi

Sci Rep· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.
Hasan Cagri Yildirim, Caner Kapar, Baris Koksal, Mustafa Seyyar, Pervin Can Sanci, Ali Alkan

J Chemother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated serum magnesium levels prompt favourable outcomes in cancer patients treated with immune checkpoint blockers.
Sait Kitapli, Ali Alkan, Ozgur Tanriverdi

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.
Nargiz Majidova, Hacı Arak, Faruk Recep Ozalp, Onur Bas, Gulhan Ozcelik Koker, Ali Alkan

Sci Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study.
İsmail Beypınar, Hacer Demir, Şendağ Yaslıkaya, Tolga Köşeci, Bilgin Demir, Ali Alkan

Breast Cancer Res Treat· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Uric Acid Level May Be a Predictive Factor for BRAF V600E Mutation in Older Patients with Metastatic Colorectal Cancer: An Exploratory Analysis.
Ali Alkan, Gümran İlay Doğaner, Özgür Tanrıverdi

Oncology· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab versus aflibercept with FOLFIRI after FOLFOX and bevacizumab in RAS mutant metastatic colon cancer a Turkish oncology group study.
Serhat Sekmek, Sema Nur Ozsan Çelebi, Dogan Bayram, Cihan Erol, Fahriye Tugba Kos, Ali Alkan

Sci Rep· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study.
Neslihan Özyurt, Ali Alkan, Burcu Gülbağcı, Mustafa Seyyar, Esra Aşık, Ziya Kalkan

Sci Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Pembrolizumab Plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: A Nationwide Retrospective Turkish Oncology Group Study.
Ebru Karci, Ahmet Bilici, Buket Bayram, Melisa Celayir, Neslihan Ozyurt, Ali Alkan

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death anxiety-we have more to go.
Ali Alkan, Sait Kitaplı, Özgür Tanrıverdi

Support Care Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum uric acid level can predict asymptomatic brain metastasis at diagnosis in patients with small cell lung cancer.
Gizem Agtas, Ali Alkan, Özgür Tanriverdi

J Egypt Natl Canc Inst· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 and Carcinogenesis: Exploring the Hidden Links.
Özgür Tanrıverdi, Ali Alkan, Turan Karaoglu, Sait Kitaplı, Aysegul Yildiz

Cureus· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of anthracycline-containing and anthracycline-free regimens in neoadjuvant HER-2 positive breast cancer treatment.
Murat Bardakci, Hilal Karakas, Dogan Bayram, Nilufer Avci, Sait Kitapli, Ali Alkan

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Concurrent Chemoradiotherapy (CRT) plus Docetaxel-Cisplatin-Fluorouracil (DCF) versus CRT plus Fluorouracil-Folinic Acid (FUFA) in Stage III Gastric Cancer.
Ali Alkan, Dilşa Mızrak, Arzu Yaşar, Ebru Karcı, Elif Berna Köksoy

J Cancer Res Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thickness Gradient in Polymer Coating by Reactive Layer-by-Layer Assembly on Solid Substrate.
Sezer Özenler, Ali Ata Alkan, Ufuk Saim Gunay, Ozgün Daglar, Hakan Durmaz

ACS Omega· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis